CLBT
The table below shows Cellebrite DI Ltd.'s balance sheet line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash & equivalents | $124.46M | $191.66M | $189.52M | - |
| Short-term investments | $151.54M | $101.82M | $38.69M | - |
| Receivables | $104.97M | $82.36M | $77.27M | $67.50M |
| Inventory | $7.60M | $8.94M | $9.94M | $6.51M |
| Total current assets | $575.85M | $567.59M | $422.08M | $273.21M |
| Property, plant & equipment | $22.21M | $17.00M | $15.90M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $16.76M |
| Goodwill | $119.56M | $28.71M | $26.83M | $26.83M |
| Total assets | $938.85M | $690.57M | $532.88M | $339.78M |
| Accounts payable | - | - | - | - |
| Total current liabilities | $369.66M | $295.50M | $253.82M | $186.57M |
| Long-term debt | - | - | - | - |
| Total liabilities | $454.53M | $354.55M | $498.67M | $413.13M |
| Retained earnings | -$86.54M | -$164.86M | $118.14M | $78.44M |
| Total equity | $484.32M | $336.02M | $34.21M | -$73.35M |